HB 5350 is a broad cannabis, hemp, and infused beverage regulation bill that revises Connecticut’s controlled substance, tax, municipal authority, and cannabis-market statutes. A major theme of the bill is terminology and structural cleanup: it replaces many references to “marijuana” with “cannabis,” updates definitions across the general statutes, and aligns related provisions governing medical cannabis, adult-use cannabis, hemp-derived products, testing, labeling, and enforcement. It also expands or clarifies the roles of the Department of Consumer Protection, the Social Equity Council, and other agencies in regulating the cannabis market.
The bill makes substantial policy changes to the cannabis and hemp markets. It expands access for qualifying out-of-state patients and caregivers, revises medical cannabis dispensing and pharmacist consultation requirements, and updates rules for dispensaries, hybrid retailers, retailers, producers, cultivators, micro-cultivators, transporters, and testing laboratories. It also creates or modifies rules for infused beverages and high-THC beverages, including licensing, product limits, labeling, age verification, retail channels, and fees. In addition, it changes municipal authority over cannabis use on municipal property, public consumption, and local regulation, while also updating impaired-driving and boating provisions to allow courts to take judicial notice of cannabis impairment effects.
The bill’s impact on state law is extensive. It amends dozens of statutes to conform to the new cannabis framework, including tax provisions, public health rules, motor vehicle laws, drug paraphernalia rules, zoning-related municipal powers, and consumer protection enforcement. It also strengthens and extends the state’s cannabis regulatory infrastructure by directing the Department of Consumer Protection to issue policies and regulations on testing, packaging, potency, product safety, delivery, and tracking, and by preserving or expanding the Social Equity Council’s oversight of licensing, workforce plans, and ownership changes in equity-related cannabis businesses. The bill also cancels certain outstanding liabilities and assessments tied to prior marijuana-related tax obligations.
The general sentiment reflected in the voting history appears mixed to negative, with the bill advancing through some stages but facing significant resistance on the floor. The joint favorable substitute passed committee 12-8, and the House ultimately passed the amended bill 81-61, but several proposed House amendments failed, and the Senate votes shown were largely unsuccessful, with multiple roll calls failing by wide margins. That pattern suggests the bill had meaningful support but also substantial concern among legislators about its scope and policy direction.
The main points of contention appear to center on the breadth of the regulatory changes, the expansion of cannabis and hemp product markets, and the balance between public health safeguards and market access. Likely areas of disagreement include infused beverage rules, THC potency limits, out-of-state patient access, municipal control, social equity licensing and ownership restrictions, and the extent of administrative authority given to the Department of Consumer Protection and the Social Equity Council. The bill’s detailed rules on advertising, packaging, testing, and business ownership also suggest concern about youth access, product safety, and market concentration versus industry flexibility and equity goals.
HB 5350 substantially revises Connecticut’s cannabis and hemp regulatory framework by amending numerous statutes to replace marijuana terminology with cannabis, expand and clarify licensing and operational rules, and add new provisions for infused beverages, high-THC beverages, testing, labeling, delivery, and product safety. It also affects tax law, municipal authority, public health rules, motor vehicle and boating impairment provisions, and social equity oversight. The bill increases the regulatory responsibilities of the Department of Consumer Protection and the Social Equity Council, while also creating new compliance obligations for cannabis establishments, hemp-related businesses, and infused beverage manufacturers.
The bill appears to have received mixed but ultimately divided support. It cleared committee and passed the House, but several House amendments failed and the Senate roll calls shown were largely unsuccessful, indicating substantial disagreement. Overall, the discussion and voting pattern suggest support for modernizing and expanding the cannabis/hemp framework, but significant concern about the bill’s size, complexity, and policy tradeoffs.
The most notable areas of contention are the bill’s broad expansion of cannabis and hemp commerce, the regulation of infused beverages and THC limits, and the extent of state control over licensing, product standards, and business ownership changes. Legislators also appear divided over social equity provisions, including ownership restrictions, workforce plans, and council oversight, as well as over municipal authority, public consumption rules, and the balance between consumer access and public health protections. The failed amendments and split votes suggest disagreement over whether the bill goes too far in liberalizing the market or too far in restricting it through detailed regulation.